Five impact areas are identified: glycemic profile, inflammation, oxidative stress, lipid profile, and hormonal profile, each linked to metabolic and endocrine alterations characteristic of PCOS
They are harder to digest, and when paired with the delayed gastric emptying caused by GLP-1 medications, they can lead to increased nausea, indigestion, and a feeling of fullness that lingers uncomfortably
Activation of 7nAChRs has anti-inflammatory, antiapoptotic, and antioxidant properties through different pathways, which is beneficial in combating neuronal abnormalities seen in ASD [72]
By activating GLP-1 and GIP receptors, it enhances insulin secretion, reduces appetite, slows gastric emptying, and improves blood glucose control
GLP-1 medications are protein-based biologics susceptible to degradation from temperature extremes, requiring refrigeration between 2C and 8C before opening